Skip to main content
. 2007 Feb 28;75(2):121–128. doi: 10.1016/j.antiviral.2007.01.158

Table 3.

Effect of the administration of IFN-αA initiated 3 or 24 h after mice infection (i.p.) with OROV or GROV

Treatment (after infection) Viruses Survived/total (percent survival)
MTDa ± S.D. (days)
Placebo IFN-αA Placebo IFN-αA
3 h OROV 1/9(11%) 3/9 (33%) 5.0 ± 2.8 6.5 ± 2.1
GROV 0/9 8/9 (88%)b 6.5 ± 2.1 >20



24 h GROV 0/9 2/9 (22%) 7.0 ± 2.8 7.0 ± 2.8
a

Mean time to death.

b

p < 0.001; Fisher's Exact test.